Blog Posts focused on: Sound Life Project (SLP); Type 1 Diabetes (T1D); Biorepository

Matt Dufort, PhD: Crunching Data to Cure Diabetes
Matt Dufort, PhD, fights diabetes one data point at a time. Matt is a bioinformatician at Benaroya Research Institute at Virginia Mason (BRI), where he’s been using his data wrangling and analysis skills to find ways to prevent pancreatic damage in people living with type 1 diabetes (T1D).

Innovative Collaboration Brings Researchers Closer to Understanding Type 1
What is the difference between an individual whose pancreas will continue producing insulin for 50 years, versus someone whose body may suddenly stop generating it within the next 18 months? That is the question Cate Speake, PhD, spends her days trying to answer.

Going Public: How Businesses Can Accommodate Your Needs
Managing your autoimmune disease may require quick and easy access to a bathroom, checking your blood sugar in public, finding a step-free route into a store, or knowing that safe foods will be on the menu.

Breakthrough Study Delays Type 1 Diabetes
Megan and Madeline Coder are twins who do everything together — like ballet and even raising sheep in their hometown, Battle Ground, Washington. But in the fall of 2014, when Megan was nine, she learned she had something that Madeline didn’t: type 1 diabetes (T1D).

Parenting a Child With T1D: This Might Sound Familiar
My son Peter was diagnosed with type 1 diabetes in 2013, just a few days before his third birthday. The years since have been a trial-by-fire learning experience.

Personalizing Treatment for Type 1 Diabetes
BRI’s Matt Dufort, PhD, and Peter Linsley, PhD, led two new studies that could help doctors predict how quickly type 1 diabetes (T1D) will progress in some people, and match them with treatments that could slow it down. Dr.

A Research Pioneer Gives Back
In the late 1970s, Virginia Mason researchers had a groundbreaking idea: Use a portable pump to deliver insulin in patients with type 1 diabetes (T1D).

Pursuing a Revolution in IBD Treatment
Treatment options for inflammatory bowel disease (IBD) have been limited for most of Elisa Boden, MD’s career. Until a few years ago, she and her colleagues – including James Lord, MD, PhD, and Michael Chiorean, MD – have had only a few types of medications to treat IBD.

Growing From the Disease He’ll Never Outgrow
"My son Peter is one of eight students at his elementary school with type 1 diabetes. Ranging in age from 5 to 10, the diabetes kids are part of a small but mighty community built on care, comfort and normalcy."

Biking 800 Miles to Get Closer to a Cure
Some people go the extra mile for their favorite cause.